百望股份联手华恒生物 为财务数智化转型筑牢合规底座

Core Insights - The collaboration between Baiwang Co., Ltd. and Anhui Huaheng Biotechnology Co., Ltd. aims to leverage AI technology to create intelligent financial and tax solutions, enhancing compliance and efficiency in financial digital transformation [1][2] Group 1: Company Profiles - Baiwang Co., Ltd. is a leading data intelligence enterprise in China, focusing on "data + AI" innovation, with a core asset of massive, real-time transaction data [1] - Anhui Huaheng Biotechnology Co., Ltd. is a high-tech enterprise specializing in synthetic biology, providing innovative and sustainable products in various fields such as animal nutrition and functional foods [1] Group 2: Collaboration Details - The partnership focuses on digital invoice management and electronic accounting file management, aiming to empower Huaheng's financial management system with intelligent upgrades [2] - Baiwang will assist Huaheng in building an integrated input invoice pool, automating the entire process of invoice collection, verification, and deduction certification, significantly enhancing management efficiency and data accuracy [2] - Baiwang's capabilities include multi-language invoice intelligent parsing, which will help Huaheng manage overseas invoices more effectively [2] Group 3: Future Directions - The collaboration is set to deepen in the field of financial digitalization, aiming to break down regional barriers and support Chinese enterprises in achieving compliant operations and efficient development in market competition [3]

AHB-百望股份联手华恒生物 为财务数智化转型筑牢合规底座 - Reportify